Related Experiment Video
Updated: May 26, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Association of Statin Therapy with Functional Outcomes and Survival in Intracerebral and Subarachnoid Hemorrhage
Bahadar S Srichawla1, Daksha Gopal1, Majaz Moonis1
1Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Insights
Statin therapy, including low- and high-intensity, improved functional outcomes for patients with intracerebral hemorrhage (ICH). For subarachnoid hemorrhage (SAH) patients, statins may offer a survival benefit, suggesting neuroprotective effects in hemorrhagic stroke.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH) are severe stroke types with significant morbidity and mortality.
- Statins (HMG-CoA reductase inhibitors) possess lipid-lowering and potential neuroprotective/anti-inflammatory properties.
Purpose of the Study:
- To evaluate the impact of statin therapy on functional outcomes and survival in patients with ICH and SAH.
- To investigate the association between different statin intensities and stroke outcomes.
Main Methods:
- Retrospective cohort study using the Get With The Guidelines (GWTG) stroke registry (January 2008 - June 2022).
- Patients categorized into no statin, low-intensity statin, or high-intensity statin groups.
- Primary outcome: Modified Rankin Scale (mRS) score at discharge (good: 0-2, poor: 3-6); multivariate logistic regression adjusted for age, gender, and NIHSS.
Main Results:
- In ICH patients (n=663), both low-intensity (aOR 2.56) and high-intensity (aOR 2.445) statin therapy were significantly associated with good functional outcomes.
- In SAH patients (n=159), all 39 deaths occurred in the no-statin group, suggesting a potential survival benefit.
Conclusions:
- Both low- and high-intensity statin therapy are linked to improved functional outcomes in ICH.
- Statin therapy may provide a survival benefit in SAH patients.
- Findings suggest a potential neuroprotective role for statins in hemorrhagic stroke, warranting further investigation.
Abstract:
Background/Objectives: Intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH) are severe forms of stroke with high morbidity and mortality rates. HMG-CoA reductase inhibitors, commonly referred to as statins, known for their lipid-lowering abilities, also possess pleiotropic properties, including anti-inflammatory and neuroprotective effects. We aimed to evaluate the impact of statin therapy on the functional outcomes and survival in patients with ICH and SAH. Methods: This retrospective cohort study analyzed data from the Get With The Guidelines (GWTG) stroke registry at a tertiary care center, including patients diagnosed with ICH or SAH between January 2008 and June 2022. Patients were categorized based on prior initiation of statin therapy: no statin, low-intensity statin, or high-intensity statin. The primary outcome was the Modified Rankin Scale (mRS) score at discharge, dichotomized to good (0-2) and poor (3-6) outcomes. A multivariate logistic regression model controlled for age, gender, and National Institutes of Health Stroke Scale (NIHSS) score at admission. Results: A total of 663 patients with ICH and 159 patients with SAH were included in the analysis. In the ICH patients, low-intensity statin therapy was associated with significantly higher odds of a good functional outcome (aOR 2.56, 95% CI 1.247-5.246, p = 0.0104), as was high-intensity statin therapy (aOR 2.445, 95% CI 1.313-4.552, p = 0.0048). Among the SAH patients, all 39 deaths occurred in the no statin therapy group. Conclusions: Both low- and high-intensity statin therapy are associated with improved functional outcomes in ICH and may offer a survival benefit in SAH. These findings highlight the potential neuroprotective role of statins in hemorrhagic stroke. Further prospective studies and randomized controlled trials are needed to confirm these observations and to clarify the optimal use of statins in this patient population.
More Related Videos
09:41Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
Published on: July 3, 2014
09:14Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021